共 28 条
- [21] Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer (vol 58, pg 1258, 2004) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (03): : 921 - 921
- [28] Nivolumab plus ipilimumab versus carboplatin-based doublet as first-line treatment for patients with advanced non-small-cell lung cancer aged ≥70 years or with an ECOG performance status of 2 (GFPC 08-2015 ENERGY): a randomised, open-label, phase3 study (vol 13, pg 141, 2025) LANCET RESPIRATORY MEDICINE, 2025, 13 (02): : e11 - e11